Evidence map›Paper›PMID 41136807›Full record

ArticleVirus genes2025

A new polymycovirus infecting a clinical isolate of the entomopathogenic and fungicolous fungus Lecanicillium aphanocladii affects pigmentation, sporulation, and antifungal susceptibility of its host.

Gulce Edis, Ilgaz Akata, Nuray Gundogdu, Ertugrul Kaya, Ergin Sahin

Abstract read
PubMed Publisher
In one paragraph

Article in Virus genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gulce EdisGraduate School of Natural and Applied Sciences, Ankara University, Ankara, Turkey.
Ilgaz AkataFaculty of Science, Department of Biology, Ankara University, Ankara, Turkey.
Nuray GundogduMedical Microbiology Laboratory, Atatürk Training and Research Hospital, Izmir, Turkey.
Ertugrul KayaFaculty of Medicine, Department of Medical Pharmacology, Omer Halis Demir University, Nigde, Turkey.
Ergin SahinFaculty of Science, Department of Biology, Dokuz Eylul University, Izmir, Turkey. ergin.sahin@deu.edu.tr.

Funding

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 122Z630
6 · The paper itself

Abstract

The Polymycoviridae family is an expanding group of mycoviruses, generally characterized by atypical capsids and segmented double-stranded (ds) RNA genomes. Polymycoviruses have been associated with various changes in their hosts' traits, such as shifts in spore production, changes in pigmentation, and alterations in growth and virulence, either enhancing or reducing them. Here, we report the complete genome sequence of a polymycovirus identified in an entomopathogenic, fungicolous, and keratinophilic, filamentous ascomycete species Lecanicillium aphanocladii, isolated from a patient with foot dermatophytosis (Tinea pedis). The virus, denominated Lecanicillium aphanocladii polymycovirus 1 (LaPmV1), has six genomic dsRNA segments. Phylogenetic analysis of RNA-dependent RNA polymerase (RdRp) sequences revealed that LaPmV1 is closely related to the previously reported Beauveria bassiana polymycovirus 4. Virus-curing studies revealed that LaPmV1 regulates pigmentation and decreases sporulation in its host while not affecting mycelial growth in vitro. LaPmV1 has also been shown to slightly increase the host's susceptibility to certain common antifungals, including itraconazole, voriconazole, and posaconazole.

Indexed as

AscomycotaFungal VirusesHypocrealesAntifungal AgentsGenome, ViralHumansPhylogenyPigmentationRNA, ViralRNA VirusesSpores, FungalAntifungal AgentsRNA, ViralAntifungal susceptibilityLecanicillium sp.Phenotypic effectsPolymycovirusViral diversity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.